Theragene Pharmaceuticals, Inc. — Form D
Theragene Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-13. The offering totals $2.0M, of which $348K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-03-13
- Form: D
- Accession: 0001601923-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $348K
- Remaining: $1.7M
- Minimum investment: $5K
- Investors: 7
- Date of first sale: 2014-02-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-213512
Issuer
- Name: Theragene Pharmaceuticals, Inc.
- CIK: 0001601923
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2011
- Address: 11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
- Phone: 619-788-2383
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Steven Davis | Director | Boston, MA |
| Daniel Coury | Director | San Diego, CA |
| Chaojie Zhang | Director | San Diego, CA |
| Jon Berglin | Director | San Diego, CA |
| Jon Berglin | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More